Literature DB >> 23770146

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.

Debasish Sundi1, Oleksandr N Kryvenko2, H Ballentine Carter3, Ashley E Ross4, Jonathan I Epstein5, Edward M Schaeffer5.   

Abstract

PURPOSE: Of men with very low risk prostate cancer at biopsy recent evidence shows that black American men are at greater risk for adverse oncologic outcomes after radical prostatectomy. We studied radical prostatectomy specimens from black and white men at very low risk to determine whether there are systematic pathological differences.
MATERIALS AND METHODS: Radical prostatectomy specimens were evaluated in men with National Comprehensive Cancer Network® (NCCN) very low risk prostate cancer. At diagnosis all men underwent extended biopsy sampling (10 or more cores) and were treated in the modern Gleason grade era. We analyzed tumor volume, grade and location in 87 black and 89 white men. For each specimen the dominant nodule was defined as the largest tumor with the highest grade.
RESULTS: Compared to white men, black men were more likely to have significant prostate cancer (61% vs 29%), Gleason 7 or greater (37% vs 11%, each p <0.001) and a volume of greater than 0.5 cm(3) (45% vs 21%, p = 0.001). Dominant nodules in black men were larger (median 0.28 vs 0.13 cm(3), p = 0.002) and more often anterior (51% vs 29%, p = 0.003). In men who underwent pathological upgrading the dominant nodule was also more frequently anterior in black than in white men (59% vs 0%, p = 0.001).
CONCLUSIONS: Black men with very low risk prostate cancer at diagnosis have a significantly higher prevalence of anterior cancer foci that are of higher grade and larger volume. Enhanced imaging or anterior zone sampling may detect these significant anterior tumors, improving the outcome in black men considering active surveillance.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AA; AS; African Americans; BMI; GS; Gleason score; MRI; PCa; PSA; PSA density; PSAD; RP; active surveillance; black; body mass index; magnetic resonance imaging; neoplasm grading; prostate; prostate cancer; prostate specific antigen; prostatic neoplasms; radical prostatectomy; risk

Mesh:

Year:  2013        PMID: 23770146      PMCID: PMC4042393          DOI: 10.1016/j.juro.2013.06.021

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.

Authors:  Cristina Magi-Galluzzi; Toyonori Tsusuki; Paul Elson; Kelly Simmerman; Chris LaFargue; Raquel Esgueva; Eric Klein; Mark A Rubin; Ming Zhou
Journal:  Prostate       Date:  2010-09-28       Impact factor: 4.104

2.  Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.

Authors:  J W Moul; T H Douglas; W F McCarthy; D G McLeod
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

3.  High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.

Authors:  Yoshinobu Komai; Noboru Numao; Soichiro Yoshida; Yoh Matsuoka; Yasukazu Nakanishi; Chikako Ishii; Fumitaka Koga; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  J Urol       Date:  2013-03-28       Impact factor: 7.450

4.  Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.

Authors:  Jeffrey J Tosoian; Bruce J Trock; Patricia Landis; Zhaoyong Feng; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

Review 5.  Active surveillance for prostate cancer: a systematic review of the literature.

Authors:  Marc A Dall'Era; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew R Cooperberg; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Mark S Soloway
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

6.  Racial differences and prognostic significance of tumor location in radical prostatectomy specimens.

Authors:  R Tiguert; E L Gheiler; M V Tefilli; M Banerjee; D J Grignon; W Sakr; D P Wood; I J Powell; J E Pontes
Journal:  Prostate       Date:  1998-12-01       Impact factor: 4.104

7.  African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?

Authors:  Debasish Sundi; Ashley E Ross; Elizabeth B Humphreys; Misop Han; Alan W Partin; H Ballentine Carter; Edward M Schaeffer
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

8.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

9.  Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis.

Authors:  Patrick J Bastian; Leslie A Mangold; Jonathan I Epstein; Alan W Partin
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

10.  Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.

Authors:  Yun-Sok Ha; Amirali Salmasi; Michael Karellas; Eric A Singer; Jeong Hyun Kim; Misop Han; Alan W Partin; Wun-Jae Kim; Dong Hyeon Lee; Isaac Yi Kim
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

View more
  60 in total

1.  Urological cancer: Poorer prostate cancer outcomes in African American men.

Authors:  Vanessa Marchesi
Journal:  Nat Rev Clin Oncol       Date:  2013-07-02       Impact factor: 66.675

2.  Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Authors:  Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg
Journal:  J Urol       Date:  2016-06-25       Impact factor: 7.450

3.  The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.

Authors:  Michael Kongnyuy; Abhinav Sidana; Arvin K George; Akhil Muthigi; Amogh Iyer; Michele Fascelli; Meet Kadakia; Thomas P Frye; Richard Ho; Francesca Mertan; M Minhaj Siddiqui; Daniel Su; Maria J Merino; Baris Turkbey; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Urol Oncol       Date:  2016-02-20       Impact factor: 3.498

4.  Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer.

Authors:  Amr Mahran; Kirtishri Mishra; Laura Bukavina; Fredrick Schumacher; Anna Quian; Christina Buzzy; Carvell T Nguyen; Vikas Gulani; Lee E Ponsky
Journal:  Int Urol Nephrol       Date:  2019-05-02       Impact factor: 2.370

Review 5.  Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Authors:  Berna C Özdemir; Gian-Paolo Dotto
Journal:  Trends Cancer       Date:  2017-03-06

6.  Is prostate cancer stage migration continuing for black men in the PSA era?

Authors:  R W Dobbs; D T Greenwald; H Wadhwa; V L Freeman; M R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-01-17       Impact factor: 5.554

Review 7.  African-American Prostate Cancer Disparities.

Authors:  Zachary L Smith; Scott E Eggener; Adam B Murphy
Journal:  Curr Urol Rep       Date:  2017-08-14       Impact factor: 3.092

8.  Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Authors:  Tino W Sanchez; Guangyu Zhang; Jitian Li; Liping Dai; Saied Mirshahidi; Nathan R Wall; Clayton Yates; Colwick Wilson; Susanne Montgomery; Jian-Ying Zhang; Carlos A Casiano
Journal:  Mol Cell Proteomics       Date:  2016-10-14       Impact factor: 5.911

Review 9.  Active surveillance for prostate cancer: current evidence and contemporary state of practice.

Authors:  Jeffrey J Tosoian; H Ballentine Carter; Abbey Lepor; Stacy Loeb
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

Review 10.  Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.

Authors:  Baris Turkbey; Anna M Brown; Sandeep Sankineni; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  CA Cancer J Clin       Date:  2015-11-23       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.